Ident. | Authors (with country if any) | Title |
---|
000020 |
Cristina Nombela [Royaume-Uni] ; James B. Rowe [Royaume-Uni] ; Sophie E. Winder-Rhodes [Royaume-Uni] ; Adam Hampshire [Royaume-Uni] ; Adrian M. Owen [Canada] ; David P. Breen [Royaume-Uni] ; Gordon W. Duncan [Royaume-Uni] ; Tien K. Khoo [Australie] ; Alison J. Yarnall [Royaume-Uni] ; Michael J. Firbank [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Trevor W. Robbins [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] ; David J. Brooks [Royaume-Uni, Danemark] ; David J. Burn [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study |
000049 |
Nir Lipsman [Canada] ; D. Blake Woodside [Canada] ; Peter Giacobbe [Canada] ; Clement Hamani [Canada] ; Jacqueline C. Carter [Canada] ; Sarah Jane Norwood [Canada] ; Kalam Sutandar [Canada] ; Randy Staab [Canada] ; Gavin Elias [Canada] ; Christopher H. Lyman [États-Unis] ; Gwenn S. Smith [États-Unis] ; Andres M. Lozano [Canada] | Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial |
000066 |
Leigh Christopher [Canada] ; Antonio P. Strafella [Canada] | Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease |
000078 |
Ned Jenkinson [Royaume-Uni] ; Andrea A. Kühn [Allemagne] ; Peter Brown [Royaume-Uni] | Gamma oscillations in the human basal ganglia |
000082 |
Maria Gabriela Sanchez [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys |
000087 |
Jolyn N. A. D'Andrea [Canada] ; Angela M. Haffenden [Canada] ; Sarah Furtado [Canada] ; Oksana Suchowersky [Canada] ; Bradley G. Goodyear [Canada] | Degradation of stored movement representations in the parkinsonian brain and the impact of levodopa |
000097 |
Giorgio Fuggetta [Royaume-Uni] ; NOR AZILA NOH [Royaume-Uni, Malaisie] | A neurophysiological insight into the potential link between transcranial magnetic stimulation, thalamocortical dysrhythmia and neuropsychiatric disorders |
000104 |
WEI SONG [Canada] ; Hillel Zukor [Canada] ; Shih-Hsiung Lin [Canada] ; Adrienne Liberman [Canada] ; Ayda Tavitian [Canada] ; Jeannie Mui [Canada] ; Hojatollah Vali [Canada] ; Carine Fillebeen [Canada] ; Kostas Pantopoulos [Canada] ; Ting-Di Wu [France] ; Jean-Luc Guerquin-Kern [France] ; Hyman M. Schipper [Canada] | Unregulated brain iron deposition in transgenic mice over-expressing HMOX1 in the astrocytic compartment |
000115 |
D. Domenger [Canada] ; D. Dea [Canada] ; L. Theroux [Canada] ; L. Moquin [Canada] ; A. Gratton [Canada] ; J. Poirier [Canada] | The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain |
000120 |
Sébastien Helie [États-Unis] ; Erick J. Paul [États-Unis] ; F. Gregory Ashby [États-Unis] | Simulating the effects of dopamine imbalance on cognition: From positive affect to Parkinson's disease |
000173 |
Golnasim Riahi [Canada] ; Marc Morissette [Canada] ; Daniel Levesque [Canada] ; Claude Rouillard [Canada] ; Pershia Samadi [Canada] ; Martin Parent [Canada] ; Thérèse Di Paolo [Canada] | Effect of chronic L-DOPA treatment on 5-HT1A receptors in parkinsonian monkey brain |
000175 |
S. Al-Sweidi [Canada] ; M. Morissette [Canada] ; T. Di Paolo [Canada] | Effect of Oestrogen Receptors on Brain NMDA Receptors of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mice |
000176 |
Julia Sacher [Canada, Allemagne] ; Eugenii A. Rabiner [Canada] ; Michael Clark [Canada] ; Pablo Rusjan [Canada] ; Alexandra Soliman [Canada] ; Rada Boskovic [Canada] ; Stephen J. Kish [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Jeffrey H. Meyer [Canada] | Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study |
000192 |
Mélanie Vendette [Canada] ; Jacques Montplaisir [Canada] ; Nadia Gosselin [Canada] ; Jean-Paul Soucy [Canada] ; Ronald B. Postuma [Canada] ; Thien Thanh Dang-Vu [Canada, Belgique] ; Jean-François Gagnon [Canada] | Brain Perfusion Anomalies in Rapid Eye Movement Sleep Behavior Disorder with Mild Cognitive Impairment |
000197 |
YILONG MA [États-Unis] ; SHUCHUN PENG [États-Unis] ; Phoebe G. Spetsieris [États-Unis] ; Vesna Sossi [Canada] ; David Eidelberg [États-Unis] ; Doris J. Doudet [Canada] | Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism |
000204 |
Richard Camicioli [Canada] ; Jennifer Sabino [Canada] ; Myrlene Gee [Canada] ; Thomas Bouchard [Canada] ; Nancy Fisher [Canada] ; Chris Hanstock [Canada] ; Derek Emery [Canada] ; W. R. Wayne Martin [Canada] | Ventricular Dilatation and Brain Atrophy in Patients with Parkinson's Disease with Incipient Dementia |
000214 |
Darcy Litteljohn [Canada] ; Eric Nelson [Canada] ; Cheri Bethune [Canada] ; Shawn Hayley [Canada] | The effects of paraquat on regional brain neurotransmitter activity, hippocampal BDNF and behavioural function in female mice |
000258 |
JING GUO [République populaire de Chine] ; Jun-Kang Shen [République populaire de Chine] ; LAN WANG [République populaire de Chine] ; LI XIAO [République populaire de Chine] ; Rong-Jun Zhang [République populaire de Chine] ; Wei-Feng Luo [République populaire de Chine] ; Zhi-Gang Gong [République populaire de Chine] ; JING SUN [République populaire de Chine] ; HAN XU [République populaire de Chine] ; Pierre Sirois [Canada] ; KAI LI [République populaire de Chine] | In Vivo Evaluation of Cerebral Transplantation of Resovist-Labeled Bone Marrow Stromal Cells in Parkinson's Disease Rats Using Magnetic Resonance Imaging |
000259 |
Francesca Antonelli [Canada] ; Nicola Ray [Canada] ; Antonio P. Strafella [Canada] | Impulsivity and Parkinson's disease: More than just disinhibition |
000270 |
Edward A. Neuwelt [États-Unis] ; Björn Bauer [États-Unis] ; Christoph Fahlke [Allemagne] ; Gert Fricker [Allemagne] ; Constantino Iadecola [États-Unis] ; Damir Janigro [États-Unis] ; Luc Leybaert [Belgique] ; Zoltán Molnar [Royaume-Uni] ; Martha E. O'Donnell [États-Unis] ; John T. Povlishock [États-Unis] ; Norman R. Saunders [Australie] ; Frank Sharp [États-Unis] ; Danica Stanimirovic [Canada] ; Ryan J. Watts [États-Unis] ; Lester R. Drewes [États-Unis] | Engaging neuroscience to advance translational research in brain barrier biology |
000281 |
Emily Bell [Canada] ; Bruce Maxwell [Canada] ; Mary Pat Mcandrews [Canada] ; Abbas Sadikot [Canada] ; Eric Racine [Canada] | Deep Brain Stimulation and Ethics: Perspectives from a Multisite Qualitative Study of Canadian Neurosurgical Centers |
000286 |
Melanie Vendette [Canada] ; Jean-François Gagnon [Canada] ; Jean-Paul Soucy [Canada] ; Nadia Gosselin [Canada] ; Ronald B. Postuma [Canada] ; Maria Tuineag [Canada] ; Isabelle Godin [Canada] ; Jacques Montplaisir [Canada] | Brain Perfusion and Markers of Neurodegeneration in Rapid Eye Movement Sleep Behavior Disorder |
000322 |
Pierre-Luc Tremblay [Canada] ; Marc-Andre Bedard [Canada] ; Dominic Langlois [Canada] ; Pierre J. Blanchet [Canada] ; Martin Lemay [Canada] ; Maxime Parent [Canada] | Movement chunking during sequence learning is a dopamine-dependant process: a study conducted in Parkinson's disease |
000347 |
Myriam Lafreniere-Roula [Canada] ; Elaine Kim [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] ; Mojgan Hodaie [Canada] ; Jonathan O. Dostrovsky [Canada] | High-frequency microstimulation in human globus pallidus and substantia nigra |
000358 |
QINGJIA MENG [Canada] ; Dirk W. Luchtman [Canada] ; BOUCHAIB EL BAHH [Canada] ; Jeffrey A. Zidichouski [Canada] ; JUN YANG [Canada] ; CAI SONG [Canada] | Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices |
000361 |
Bazoumana Ouattara [Canada] ; Fabrizio Gasparini [Suisse] ; Marc Morissette [Canada] ; Laurent Gregoire [Canada] ; Pershia Samadi [Canada] ; Baltazar Gomez-Mancilla [Suisse] ; Thérèse Di Paolo [Canada] | Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys |
000371 |
Zang-Hee Cho [Corée du Sud, États-Unis] ; Hoon-Ki Min [Corée du Sud, États-Unis] ; Se-Hong Oh [Corée du Sud] ; Jae-Yong Han [Corée du Sud] ; Chan-Woong Park [Corée du Sud] ; Je-Geun Chi [Corée du Sud] ; Young-Bo Kim [Corée du Sud] ; SUN HA PAEK [Corée du Sud] ; Andres M. Lozano [Canada] ; Kendall H. Lee [États-Unis] | Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging: Clinical article |
000373 |
Stephen J. Kish [Canada] ; Jason Lerch [Canada] ; Yoshiaki Furukawa [Canada, Japon] ; Junchao Ton [Canada] ; Tina Mccluskey [Canada] ; Diana Wilkins [États-Unis] ; Sylvain Houle [Canada] ; Jeffrey Meyer [Canada] ; Emanuela Mundo [Italie] ; Alan A. Wilson [Canada] ; Pablo M. Rusjan [Canada] ; Jean A. Saint-Cyr [Canada] ; Mark Guttman [Canada] ; D. Louis Collins [Canada] ; Colin Shapiro [Canada] ; Jerry J. Warsh [Canada] ; Isabelle Boileau [Canada] | Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study |
000385 |
JUNCHAO TONG [Canada] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Lee C. Ang [Canada] ; Lysia S. Forno [États-Unis] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Manfred D. Muenter [États-Unis] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada, Japon] | Brain α-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation |
000390 |
Cathy Lu [Canada] ; Aamir Bharmal [Canada] ; Zelma H. Kiss [Canada] ; Oksana Suchowersky [Canada] ; Angela M. Haffenden [Canada] | Attention and reach-to-grasp movements in Parkinson's disease |
000407 |
Peter Giacobbe [Canada] ; Helen S. Mayberg [États-Unis] ; Andres M. Lozano [Canada] | Treatment resistant depression as a failure of brain homeostatic mechanisms: Implications for deep brain stimulation : BRAIN SIMULATION IN PSYCHIATRY |
000408 |
Elan D. Louis [États-Unis] ; Phyllis L. Faust [États-Unis] ; Jean-Paul G. Vonsattel [États-Unis] ; Lawrence S. Honig [États-Unis] ; Alex Rajput [Canada] ; Ali Rajput [Canada] ; Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] ; Webster G. Ross [États-Unis] ; Rodger J. Elble [États-Unis] ; Cordelia Erickson-Davis [États-Unis] ; Carol B. Moskowitz [États-Unis] ; Arlene Lawton [États-Unis] | Torpedoes in Parkinson's Disease, Alzheimer's Disease, Essential Tremor, and Control Brains |
000420 |
Emily Bell [Canada] ; Ghislaine Mathieu [Canada] ; Eric Racine [Canada] ; Konstantin V. Slavin [États-Unis] | Preparing the ethical future of deep brain stimulation. Commentary |
000425 |
Benedicte Ballanger [Canada, France] ; Marjan Jahanshahi [Royaume-Uni] ; Emmanuel Broussolle [France] ; Stéphane Thobois [France] | PET functional imaging of deep brain stimulation in movement disorders and psychiatry |
000435 |
Myriam Lafreniere-Roula [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] ; Mojgan Hodaie [Canada] ; Jonathan O. Dostrovsky [Canada] | Microstimulation-induced inhibition as a tool to aid targeting the ventral border of the subthalamic nucleus: Clinical article |
000436 |
Pershia Samadi [Canada] ; Alex Rajput [Canada] ; Frédéric Calon [Canada] ; Laurent Gregoire [Canada] ; Oleh Homykiewicz [Canada, Autriche] ; Ali H. Rajput [Canada] ; Thèrèse Di Paolo [Canada] | Metabotropic Glutamate Receptor II in the Brains of Parkinsonian Patients |
000464 |
Hyman M. Schipper [Canada] ; WEI SONG [Canada] ; Hillel Zukor [Canada] ; Jacob R. Hascalovici [Canada] ; David Zeligman [Canada] | Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement |
000465 |
Hillel Zukor [Canada] ; WEI SONG [Canada] ; Adrienne Liberman [Canada] ; JEANNIE MUI [Canada] ; Hojatollah Vali [Canada] ; Carine Fillebeen [Canada] ; Kostas Pantopoulos [Canada] ; Ting-Di Wu [France] ; Jean-Luc Guerquin-Kern [France] ; Hyman M. Schipper [Canada] | HO-1-mediated macroautophagy : a mechanism for unregulated iron deposition in aging and degenerating neural tissues |
000470 |
Kenneth D. Cronin [États-Unis] ; DONGLIANG GE [États-Unis] ; Paul Manninger [Canada] ; Colton Linnertz [États-Unis] ; Anna Rossoshek [États-Unis] ; Bonnie M. Orrison [États-Unis] ; David J. Bernard [États-Unis] ; Omar M. A. Ei-Agnaf [Émirats arabes unis] ; Michael G. Schlossmacher [Canada] ; Robert L. Nussbaum [États-Unis] ; Ornit Chiba-Falek [États-Unis] | Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain |
000488 |
Benedicte Ballanger [Canada] ; Andres M. Lozano [Canada] ; Elena Moro [Canada] ; Thilo Van Eimeren [Canada] ; Clement Hamani [Canada] ; Robert Chen [Canada] ; Roberto Cilia [Canada] ; Sylvain Houle [Canada] ; YU YAN POON [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada] | Cerebral Blood Flow Changes Induced by Pedunculopontine Nucleus Stimulation in Patients With Advanced Parkinson's Disease: A [15O] H2O PET Study |
000511 |
Karin A. Stephenson [Canada] ; Erik M. Van Oosten [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Sylvain Houle [Canada] ; Neil Vasdev [Canada] | Synthesis and preliminary evaluation of [18F]-fluoro-(2S)-Exaprolol for imaging cerebral β-adrenergic receptors with PET |
000513 |
Jasper E. Visser [Pays-Bas, Suisse] ; John H. J. Allum [Suisse] ; Mark G. Carpenter [Suisse, Canada] ; Rianne A. Esselink [Pays-Bas] ; Johannes D. Speelman [Pays-Bas] ; George F. Borm [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] | Subthalamic nucleus stimulation and levodopa-resistant postural instability in Parkinson's disease |
000514 |
Anthony P. Nicholas [États-Unis] ; Farah D. Lubin [États-Unis] ; Penelope J. Hallett [États-Unis] ; Padmapriya Vattem [États-Unis] ; Paula Ravenscroft [Royaume-Uni] ; Erwan Bezard [France] ; SHAOBO ZHOU [Royaume-Uni] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] ; J. David Sweatt [États-Unis] ; David G. Standaert [États-Unis] | Striatal histone modifications in models of levodopa-induced dyskinesia |
000525 |
Moran Weinberger [Canada] ; Clement Hamani [Canada] ; William D. Hutchison [Canada] ; Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Jonathan O. Dostrovsky [Canada] | Pedunculopontine nucleus microelectrode recordings in movement disorder patients |
000536 |
Clement Hamani [Canada] ; Elena Moro [Canada] ; Cindy Zadikoff [Canada] ; Yu-Yan Poon [Canada] ; Andres M. Lozano [Canada] ; Philip A. Starr ; Julie G. Pilitsis ; Roy A. E. Bakay ; Robert G. Grossman | LOCATION OF ACTIVE CONTACTS IN PATIENTS WITH PRIMARY DYSTONIA TREATED WITH GLOBUS PALLIDUS DEEP BRAIN STIMULATION |
000537 |
Jorge Guridi [Espagne] ; Jose A. Obeso [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Andres A. Lozano [Canada] ; Miguel Manrique [Espagne] ; Philip A. Starr ; Julie G. Pilitsis ; Roy A. E. Bakay ; Marwan I. Hariz ; Ventura Arjona ; Jose G. Martin-Rodriguez | L-DOPA-INDUCED DYSKINESIA AND STEREOTACTIC SURGERY FOR PARKINSON'S DISEASE. Commentaries |
000538 |
Connie Marras [Canada] ; Anthony Lang [Canada] | Invited Article: Changing concepts in Parkinson disease : Moving beyond the Decade of the Brain |
000544 |
A. H. Rajput [Canada] ; H. H. Sitte [Autriche] ; A. Rajput [Canada] ; M. E. Fenton [Canada] ; C. Pifl [Autriche] ; O. Hornykiewicz [Autriche] | Globus pallidus dopamine and Parkinson motor subtypes : Clinical and brain biochemical correlation |
000561 |
Francois Tremblay [Canada] ; Guillaume Leonard [Canada] ; Louis Tremblay [Canada] | Corticomotor facilitation associated with observation and imagery of hand actions is impaired in Parkinson's disease |
000563 |
Yuri M. Andrade-Souza [Canada] ; Jason M. Schwalb [Canada] ; Clement Hamani [Canada] ; Hazem Eltahawy [Canada] ; Tasnuva Hoque [Canada] ; Jean Saint-Cyr [Canada] ; Andres M. Lozano [Canada] ; Roy A. E. Bakay ; Ali R. Rezai ; Philip A. Starr | COMPARISON OF THREE METHODS OF TARGETING THE SUBTHALAMIC NUCLEUS FOR CHRONIC STIMULATION IN PARKINSON'S DISEASE |
000567 |
Clement Hamani [Canada] ; Erich Richter [Canada] ; Jason M. Schwalb [Canada] ; Andres M. Lozano [Canada] ; Roy A. E. Bakay ; Scott C. Kutz ; Alim-Louis Benabid ; Philip A. Starr ; Brian H. Kopell ; Ali R. Rezai ; Giovanni Broggi ; Angelo Franzini | BILATERAL SUBTHALAMIC NUCLEUS STIMULATION FOR PARKINSON'S DISEASE : A SYSTEMATIC REVIEW OF THE CLINICAL LITERATURE |
000568 |
Nikolai V. Malykhin [Canada] ; Thomas P. Bouchard [Canada] ; Richard Camicioli [Canada] ; Nicholas J. Coupland [Canada] | Aging hippocampus and amygdala |
000653 |
Ron Levy [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada] ; Philip A. Starr ; Julie G. Pilitsis ; Roy A. E. Bakay | Dual microelectrode technique for deep brain stereotactic surgery in humans |
000661 |
Nir Lipsman [Canada] ; Joseph S. Neimat [États-Unis] ; Andres M. Lozano [Canada] ; Philip L. Gildenberg ; Philip A. Starr ; Julie G. Pilitsis ; Roy A. E. Bakay ; Bjorn A. Meyerson ; Brian H. Kopell ; Ali R. Rezai | Deep brain stimulation for treatment-refractory obsessive-compulsive disorder : The search for a valid target. Commentary |
000722 |
Meenal Joshi [Canada] ; Rachel F. Tyndale [Canada] | Induction and recovery time course of rat brain CYP2E1 after nicotine treatment |
000751 |
S. Mazza [Canada] ; J. P. Soucy [Canada] ; P. Gravel [Canada] ; M. Michaud [Canada] ; R. Postuma [Canada] ; J. Massicotte-Marquez [Canada] ; A. Decary [Canada] ; J. Montplaisir [Canada] | Assessing whole brain perfusion changes in patients with REM sleep behavior disorder |
000824 |
GUOWEI HUANG [Canada, République populaire de Chine] ; Magdalena Dragan [Canada] ; David Freeman [Canada] ; John X. Wilson [Canada, États-Unis] | Activation of catechol-O-methyltransferase in astrocytes stimulates homocysteine synthesis and export to neurons |
000827 |
| Abstracts of the 12th World Congress of Psychophysiology the Olympics of the Brain of the International Organization of Psychophysiology (I.O.P.) associated with the United Nations, Thessaloniki, Porto Carras, Halkidiki, Greece, September 18-23, 2004 |
000866 |
Louise Normandin [Canada] ; Linda Ann Beaupre [Canada] ; Fariba Salehi [Canada] ; Annie St.-Pierre [Canada] ; Greg Kennedy [Canada] ; Donna Mergler [Canada] ; Roger F. Butterworth [Canada] ; Suzanne Philippe [Canada] ; Joseph Zayed [Canada] | Manganese distribution in the brain and neurobehavioral changes following inhalation exposure of rats to three chemical forms of manganese |
000883 |
Constantine Constantoyannis [Canada] ; Brett Heilbron [Canada] ; Christopher R. Honey [Canada] | Electrocardiogram artifacts caused by deep brain stimulation |
000909 |
Roger F. Butterworth [Canada] | Thiamin deficiency and brain disorders |
000966 |
Pierre J. Blanchet [États-Unis, Canada] ; Spiros Konitsiotis [États-Unis, Grèce] ; Hideki Mochizuki [États-Unis, Japon] ; Ryszard Pluta [États-Unis] ; Dwaine F. Emerich [États-Unis] ; Thomas N. Chase [États-Unis] ; M. Maral Mouradian [États-Unis] | Complications of a trophic xenotransplant approach in parkinsonian monkeys |
000980 |
Robert Jr Laforce [Canada] | Revue des mécanismes d'apprentissage par lesquels le striatum participe à l'apprentissage implicite d'habiletés |
000993 |
Vincenzo Di Matteo [Italie] ; Marisa Cacchio [Italie] ; Camillo Di Giulio [Italie] ; Ennio Esposito [Italie] | Role of serotonin2C receptors in the control of brain dopaminergic function |
000A07 |
Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada] | Mechanisms of deep brain stimulation |
000A10 |
André Parent [Canada] ; Martin Parent [Canada] ; Véronique Leroux-Hugon [France] | Jules Bernard Luys: A singular figure of 19th Century neurology |
000A33 |
Anthony E. Lang [Canada] ; Hakan Widner [Suède] | Deep brain stimulation for Parkinson's disease: Patient selection and evaluation |
000A37 |
Nicole Duchesne [Canada] ; Jean-Paul Soucy [Canada] ; Hélène Masson [Canada] ; Sylvain Chouinard [Canada] ; Marc-André Bedard [Canada] | Cognitive deficits and striatal dopaminergic denervation in Parkinson's disease: A single photon emission computed tomography study using 123Iodine-β-CIT in patients on and OFF levodopa |
000A39 |
Yoshiaki Furukawa [Canada] ; Sophie Vigouroux [France] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; LEE ANG [Canada] ; Marièle Briand [France] ; Stephen J. Kish [Canada] ; Yves Briand [France] | Brain proteasomal function in sporadic Parkinson's disease and related disorders |
000A43 |
Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Othman Ghribi [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Alteration of glutamate receptors in the striatum of dyskinetic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment |
000B01 |
Masafumi Fukuda [États-Unis] ; Marc Mentis [États-Unis] ; Maria Felice Ghilardi [États-Unis] ; Vijay Dhawan [États-Unis] ; Angelo Antonini [États-Unis] ; John Hammerstad [États-Unis] ; Andres M. Lozano [Canada] ; Anthony Lang [Canada] ; Kelly Lyons [États-Unis] ; William Koller [États-Unis] ; Claude Ghez [États-Unis] ; David Eidelberg [États-Unis] | Functional correlates of pallidal stimulation for Parkinson's Disease |
000B08 |
A. R. Zahran [Canada] ; N. Simmerman [Canada] ; S. Carrier [Canada] ; P. Vachon [Canada] ; Y. Sato | Erectile dysfunction occurs following substantia nigra lesions in the rat. Commentary |
000B14 |
Jun-Xia Xie [République populaire de Chine] ; MING TANG [République populaire de Chine] ; CHUNYI ZHANG [Canada] | Effect of cholecystokinin-8 microinjection into ventral tegmental area on dopamine release in nucleus accumbens of rats: An in vivo voltammetric study |
000B43 |
R. Kumar [Canada] ; A. E. Lang [Canada] ; M. C. Rodriguez-Oroz [Espagne] ; A. M. Lozano [Canada] ; P. Limousin [France] ; P. Pollak [France] ; A. L. Benabid [France] ; J. Guridi [Espagne] ; E. Ramos [Espagne] ; C. Van Der Linden [Belgique] ; A. Vandewalle [Belgique] ; J. Caemaert [Belgique] ; E. Lannoo [Belgique] ; D. Van Den Abbeele [Belgique] ; G. Vingerhoets [Belgique] ; M. Wolters [Belgique] ; J. A. Obeso [Espagne] | eep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease |
000B44 |
Y. L. Xue [République populaire de Chine] ; Z. F. Wang [République populaire de Chine] ; D. G. Zhong [République populaire de Chine] ; X. Cui [République populaire de Chine] ; X. J. Li [République populaire de Chine] ; X. J. Ma [République populaire de Chine] ; L. N. Wang [République populaire de Chine] ; K. Zhu [République populaire de Chine] ; A. M. Sun [Canada] | Xenotransplantation of microencapsulated bovine chromaffin cells into hemiparkinsonian monkeys |
000B52 |
J. Guridi [Espagne] ; M. C. Rodriguez-Oroz [Espagne] ; A. M. Lozano [Canada] ; E. Moro [Italie] ; A. Albanese [Italie] ; B. Nuttin [Belgique] ; J. Gybels [Belgique] ; E. Ramos [Espagne] ; J. A. Obeso [Espagne] | Targeting the basal ganglia for deep brain stimulation in Parkinson's disease |
000B60 |
M. Goulet [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; S. Maltais [Canada] ; P. Falardeau [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada] | Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-Monkeys |
000B61 |
S. Miksys [Canada] ; Y. Rao [Canada] ; E. M. Sellers [Canada] ; M. Kwan [Canada] ; D. Mendis [Canada] ; R. F. Tyndale [Canada] | Regional and cellular distribution of CYP2D subfamily members in rat brain |
000B68 |
M. Grandbois [Canada] ; M. Morissette [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada] | Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice |
000B72 |
P. Seeman [Canada] ; D. Nam [Canada] ; C. Ulpian [Canada] ; I. S. C. Liu [Canada] ; T. Tallerico [Canada] | New dopamine receptor, D2Longer, with unique TG splice site, in human brain |
000B73 |
L. L. Trepanier [Canada] ; R. Kumar [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] ; J. A. Saint-Cyr [Canada] | Neuropsychological outcome of GPI pallidotomy and GPI or STN deep brain stimulation in Parkinson's disease |
000B76 |
P. Ashby [Canada] ; J. C. Rothwell [Royaume-Uni] | Neurophysiologic aspects of deep brain stimulation |
000C40 |
A. Samii [Canada] ; K. Markopoulou [États-Unis] ; Z. K. Wszolek [États-Unis] ; V. Sossi [Canada] ; T. Dobko [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada] ; A. J. Stoessl [Canada] | PET studies of parkinsonism associated with mutation in the α-synuclein gene |
000C62 |
R. Grondin [Canada] ; M. Goulet [Canada] ; M. Morissette [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada] | Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958 |
000C98 |
H. M. Schipper [Canada] ; A. Liberman [Canada] ; E. G. Stopa [États-Unis] | Neural heme oxygenase-1 expression in idiopathic Parkinson's disease |
000D09 |
M. D. Muenter [États-Unis] ; L. S. Forno [États-Unis] ; O. Hornykiewicz [Autriche] ; S. J. Kish [Canada] ; D. M. Maraganore [États-Unis] ; R. J. Caselli [États-Unis] ; H. Okazaki [États-Unis] ; F. M. Jr Howard [États-Unis] ; B. J. Snow [Australie] ; D. B. Calne [Canada] | Hereditary form of parkinsonism-dementia |
000D21 |
R. R. Tasker [Canada] ; R. D. Penn [États-Unis] | Deep brain stimulation is preferable to thalamotomy for tremor suppression. Commentary |
000D33 |
T. M. Peters [Canada] ; R. M. Comeau [Canada] ; R. Kasrai [Canada] ; P. S. Jean [Canada] ; D. Clonda [Canada] ; M. Sinasac [Canada] ; M. Audette [Canada] ; A. Fenster [Canada] | A comprehensive approach to image-guided surgery |
000D46 |
J. P. Francke [France] ; R. Sigal [France] ; P. Martinat [France] ; J. P. Pruvo [France] | Anatomie sérielle et IRM des noyaux de la base et du thalamus |
000D49 |
F. J. G. Vingerhoets [Canada] ; M. Schulzer [Canada] ; D. B. Calne [Canada] ; B. J. Snow [Canada] | Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? |
000D79 |
I. Q. Whishaw [Canada] ; B. L. K. Coles [Canada] ; S. M. Pellis [Canada] ; E. I. Miklyaeva [Canada] | Impairments and compensation in mouth and limb use in free feeding after unilateral dopamine depletions in a rat analog of human Parkinson's disease |
000D94 |
M. Goulet [Canada] ; M. Morissette [Canada] ; F. Calon [Canada] ; P. J. Blanchet [Canada] ; P. Falardeau [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada] | Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression : In situ hybridization histochemical analysis |
000D99 |
C. Schwab [Canada] ; J. C. Steele [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Amyloid P immunoreactivity precedes C4d deposition on extracellular neurofibrillary tangles |
000E00 |
R. Kakkar [Canada] ; R. V. S. Raju [Canada] ; A. H. Rajput [Canada] ; R. K. Sharma [Canada] | Amantadine: an antiparkinsonian agent inhibits bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme |
000E17 |
L. Wahl [Canada] ; C. Nahmias [Canada] | Modeling of fluorine-18-6-fluoro-L-Dopa in humans |
000E18 |
O. Yasuhara [Canada] ; C. Schwab [Canada] ; A. Matsuo [Canada] ; S. U. Kim ; J. C. Steele ; I. Akiguchi ; J. Kimura ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Midkine-like immunoreactivity in extracellular neurofibrillary tangles in brains of patients with parkinsonism-dementia complex of Guam |
000E19 |
A. Lozano [Canada] ; W. Hutchison ; Z. Kiss ; R. Tasker ; K. Davis ; J. Dostrovsky | Methods for microelectrode-guided posteroventral pallidotomy |
000E25 |
G. Trepanier [Canada] ; D. Furling [Canada] ; J. Puymirat [Canada] ; M.-E. Mirault [Canada] | Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain |
000E26 |
E. I. Miklyaeva [Canada] ; I. Q. Whishaw [Canada] | HemiParkinson analogue rats display active support in good limbs versus passive support in bad limbs on a skilled reaching task of variable height |
000E27 |
F. Q. Ye [Canada] ; W. R. M. Martin ; P. S. Allen [Canada] | Estimation of brain iron in vivo by means of the interecho time dependence of image contrast |
000E35 |
C. Bergeron [Canada] ; C. Petrunka ; L. Weyer | Copper/zinc superoxide dismutase expression in the human central nervous system : correlation with selective neuronal vulnerability |
000E37 |
L. D. Morrison [Canada] ; D. D. Smith [Canada] ; S. J. Kish [Canada] | Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease |
000E52 |
H. Kuwabara [Canada] ; P. Cumming ; Y. Yasuhara ; G. C. Leger ; M. Guttman ; M. Diksic ; A. C. Evans ; A. Gjedde | Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease |
000E56 |
S. A. L. Bennett [Canada] ; B. Stevenson ; W. A. Staines ; D. C. S. Roberts | Periodic acid-Schiff(PAS)-positive deposits in brain following kainic acid-induced seizures : relationships of fos induction, neuronal necrosis, reactive gliosis, and blood-brain barrier breakdown |
000E67 |
C. Thiffault [Canada] ; N. Aumont ; R. Quirion [Canada] ; J. Poirier | Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain |
000E70 |
P. Chagnon [Canada] ; C. Betard ; Y. Robitaille ; A. Cholette ; D. Gauvreau | Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases |
000E79 |
C. Nahmias [Canada] ; L. Wahl ; R. Chirakal ; G. Firnau ; E. S. Garnett | A probe for intracerebral aromatic amino-acid decarboxylase activity : distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain |
000E80 |
R. Kanthan [Canada] ; A. Shuaib ; G. Goplen ; H. Miyashita | A new method of in-vivo microdialysis of the human brain |
000E90 |
K. H. Jhamandas [Canada] ; R. J. Boegman [Canada] ; R. J. Beninger | The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits : modulation by endogenous excitotoxin antagonists |
000F12 |
A. H. Rajput [Canada] ; W. R. G. Gibb ; X. H. Zhong ; K. S. Shannak ; S. Kish ; L. G. Chang ; O. Hornykiewicz | Dopa-responsive dystonia : pathological and biochemical observations in a case |
000F39 |
B. J. Snow [Canada] ; I. Tooyama ; E. G. Mcgeer [Canada] ; T. Yamada ; D. B. Calne [Canada] ; H. Takahashi [Canada] ; H. Kimura | Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels |
000F51 |
R. Quirion [Canada] | Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release |
000F52 |
A. P. Sen [Canada] ; P. Boksa ; R. Quirion | Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer's, Parkinson's and Huntington's diseases |
000F58 |
A. J. Flint [Canada] ; S. E. Black ; I. Campbell-Taylor ; G. F. Gailey ; C. Levinton | Abnormal speech articulation, psychomotor retardation, and subcortical dysfunction in major depression |
000F83 |
T. Yamada [Canada] ; P. L. Mcgeer ; E. G. Mcgeer | Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins |
000F94 |
M. S. Pollanen [Canada] ; C. Bergeron ; L. Weyer | Detergent-insoluble cortical lewy body fibrils share epitopes with neurofilament and τ |
001000 |
R. F. Peppard [Canada] ; R. Wayne Martin [Canada] ; G. D. Carr ; E. Grochowski ; M. Schulzer [Canada] ; M. Guttman [Canada] ; P. L. Mcgeer ; A. G. Phillips ; J. K. C. Tsui [Canada] ; D. B. Calne [Canada] | Cerebral glucose metabolism in Parkinson's disease with and without dementia |
001007 |
S. J. Kish [Canada] ; K. Shannak ; A. Rajput ; J. H. N. Deck ; O. Hornykiewicz | Aging produces a specific pattern of striatal dopamine loss : implications for the etiology of idopathic Parkinson's disease |
001017 |
M. H. Bhatt ; B. J. Snow ; W. R. Wayne Martin ; B. D. Pate ; D. B. Calne | Positron emission tomography suggests that the rate of progression of idiopthic parkinsonism is slow |
001029 |
M. Filion ; L. Tremblay ; P. J. Bedard | Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism |
001034 |
A. H. Rajput [Canada] ; B. Rozdilsky ; L. Ang ; A. Rajput | Clinicopathologic observations in essential tremor : report of six cases |
001040 |
M. Filion ; L. Tremblay | Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism |
001043 |
S. J. Kish ; L. M. Distefano ; S. Dozic ; Y. Robitaille ; A. Rajput ; J. H. N. Deck ; O. Hornykiewicz | [3H]vesamicol binding in human brain cholinergic deficiency disorders |
001050 |
M. H. Bhatt ; B. J. Snow ; W. R. W. Martin ; S. Cooper ; D. B. Calne | Positron emission tomography in Shy-Drager syndrome |
001058 |
M. Guttman ; H. C. Fibiger ; A. Jakubovic ; D. B. Calne | Intracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism |
001067 |
P. Seeman ; H. B. Niznik | Dopamine receptors and transporters in Parkinson's disease and schizophrenia |
001068 |
T. L. Perry ; J. M. Wright ; K. Berry ; S. Hansen ; T. L. Jr Perry | Dominantly inherited apathy, central hypoventilation, and Parkinson's syndrome : clinical, biochemical, and neuropathologic studies of 2 new cases |
001072 |
R. F. Peppard ; W. R. W. Martin ; C. M. Clark ; G. D. Carr ; P. L. Mcgeer ; D. B. Calne | Cortical glucose metabolism in Parkinson's and Alzheimer's disease |
001085 |
L. Tremblay ; M. Filion ; P. J. Bedard | Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism |
001086 |
R. J. Uitti ; A. H. Rajput ; B. Rozdilsky ; M. Bickis ; T. Wollin ; W. K. Yuen | Regional metal concentrations in Parkinson1s disease, other chronic neurological diseases, and control brains |
001089 |
A. H. Rajput ; R. J. Uitti ; S. Sudhakar ; B. Rozdilsky | Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei |
001093 |
G. S. Robertson ; D. G. Herrera ; M. Dragunow ; H. A. Robertson | L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra |
001113 |
P. L. Mcgeer ; S. Itagaki ; B. E. Boyes ; E. G. Mcgeer | Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains |
001114 |
P. L. Mcgeer ; S. Itagaki ; H. Akiyama ; E. G. Mcgeer | Rate of cell death in parkinsonism indicates active neuropathological process |
001124 |
J. J. Gilbert ; S. J. Kish ; LI-JAN CHANG ; C. Morito ; K. Shannak ; O. Hornykiewicz | Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates |
001128 |
R. J. Riopelle | Adrenal medulla autografts in Parkinson's disease: a proposed mechanism of action |
001146 |
A. E. Lang | Manipulating the dopaminergic system in Parkinson's disease |
001156 |
J. D. S. Mckean ; P. B. R. Allen ; L. J. Filipow ; J. D. R. Miller | CT guided functional stereotaxic surgery |
001161 |
T. L. Perry ; K. Jones ; S. Hansen ; R. A. Wall | 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets |
001171 |
T. Di Paolo ; P. Bedard ; M. Daigle ; R. Boucher | Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys |
001175 |
J. Kish ; A. Rajput ; J. Gilbert ; B. Rozdilsky ; L.-J. Chang ; K. Shannak ; O. Hornykiewicz | Elevated γ-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss |
001178 |
M. Guttman ; P. Seeman ; G. P. Reynolds ; P. Riederer ; K. Jellinger ; W. W. Tourtellotte | Dopamine D2 receptor density remains constant in treated Parkinson's disease |
001186 |
W. R. W. Martin | Positron emission tomography in movement disorders |
001188 |
R. J. Uitti ; A. H. Rajput ; E. M. Ashenhurst ; B. Rozdilsky | Cyanide-induced parkinsonism: a clinicopathologic report |